MAP Pharmaceuticals, Inc. (MAPP) Reports Q1 EPS Loss of $0.58
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Price: $28.11 --0%
Financial Fact:
Sales, general and administrative: 5.64M
Today's EPS Names:
YRD, CAG, CALM, More
Financial Fact:
Sales, general and administrative: 5.64M
Today's EPS Names:
YRD, CAG, CALM, More
Join SI Premium – FREE
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q1 EPS of ($0.58), $0.19 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $34.2 million, which may not compare to the consensus estimate of $820 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
- CarMax (KMX) Tops Q2 EPS by 43c
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
